Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Our Favorite "Liquid Biopsy" Company Has a "10× Advantage" Over Rivals, Expert Says

When I recommended TrovaGene Inc. (Nasdaq: TROV) back in March, I described it as the single-best profit idea I'd seen in months.

And the stock didn't let me down.

Shares of the San Diego-based "liquid-biopsy" company doubled in just three months after we recommended them back on March 11.

When the stock sold off after that skyrocket rally, we told you all not to worry. In fact, we advised you to turn that weakness into an opportunity - and accumulate more shares.

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK